Indirubin suppresses ovarian cancer cell viabilities through the STAT3 signaling pathway
Lihong Chen, Jinhua Wang, Jianbo Wu, Qiaomei Zheng, Jifen Hu Department of Obstetrics and Gynecology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China Background: Indirubin is the active component of Danggui Longhui Wan, a traditional Chinese medicine formulation. Due to its...
Saved in:
Main Authors: | Chen L (Author), Wang J (Author), Wu J (Author), Zheng Q (Author), Hu J (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer
by: Sheng Yin, et al.
Published: (2022) -
MS: Wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer
by: Sheng Yin, et al.
Published: (2022) -
Effects of indirubin and isatin on cell viability, mutagenicity, genotoxicity and BAX/ERCC1 gene expression
by: Manoela Viar Fogaça, et al.
Published: (2017) -
Signal Transducer and Activator of Transcription 3 (STAT3) Suppresses STAT1/Interferon Signaling Pathway and Inflammation in Senescent Preadipocytes
by: Aisha Y. Madani, et al.
Published: (2021) -
Indirubin inhibits Wnt/β-catenin signal pathway via promoter demethylation of WIF-1
by: Shou Gang Liu, et al.
Published: (2020)